Delivery Order SPE2DB22D9130-SPE2DB25FE0FG
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,645.39 by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a discrete purchase under the company's larger Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Mirena 52 mg systems, with a ceiling value of $1,041.56. The award, issued on August 6, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 27, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency for 52 mg Mirena systems valued at $1,562.31. The award, issued on September 16, 2025, with an ultimate completion date of October 7, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, valued at $5,207.70 with an ultimate completion date of August 21, 2025, was issued without a set-aside designation. The award represents a task order under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,645.39 by the Defense Logistics Agency (DLA) for Mirena 52 mg systems. The contract, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, is structured as a firm fixed-price delivery order without a set-aside designation. This award represents a direct delivery under DMS Pharmaceutical Group's existing Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $2,603.85 by the Defense Logistics Agency (DLA) for Mirena 52 mg systems. This delivery order, issued on May 30, 2025, with an ultimate completion date of June 23, 2025, represents a specific task order under the company's larger SPE2DB Indefinite Delivery Contract with DLA, valued at approximately $500 million and valid...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $26,038.50 by the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, which is scheduled for completion by September 22, 2025, was issued without a set-aside designation, allowing the contractor to compete on an unrestricted basis. The award represents a specific...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,124.68 by the Defense Logistics Agency (DLA) on September 16, 2025, for the supply of Mirena 52 mg contraceptive systems. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 7, 2025, and carries no set-aside designation. This award represents a single transaction under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $2,603.85 by the Defense Logistics Agency (DLA) for Mirena 52 mg contraceptive systems. The delivery order, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, represents a tactical procurement under the DLA's broader pharmaceutical supply infrastructure. This award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 4, 2025, for Mirena 52 mg contraceptive systems. This firm fixed-price delivery order, valued at $9,967.38, represents performance through September 25, 2025, and carries no set-aside designation. The award utilizes DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA under the...
- SPE2DB22D9130Indefinite Delivery Contract
- SPE2DB22D9130-SPE2DB25FE0FGDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $3,645.39 by the Defense Logistics Agency (DLA) for Mirena 52 mg systems. This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a task order under the company's larger single-award Indefinite Delivery Contract with DLA valued at $499.999 billion and valid through November 2026. The award utilizes no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal procurement market based on its established capabilities as a woman-owned small business. The SPE2DB program vehicle through which this delivery order was issued enables DLA to procure a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's contract portfolio with the agency demonstrates consistent success in delivering specialized pharmaceutical products, including contraceptive devices, biologics, and prescription medications. The Mirena delivery order represents another instance of the company fulfilling critical medical supply needs for military health systems, contributing to its established role as a key supplier within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 8/4/25 |